Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-02-20

Clinical Trial Update: Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy [Phase 1]

View source ↗

Summary

A Phase 1 imaging substudy on neuroinflammation in asymptomatic carotid artery disease has been withdrawn; the study is sponsored by the University of Alabama a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Critical Asymptomatic Carotid Artery Disease, Non-Critical Asymptomatic Carotid Artery Disease | Phase 1 | Status: WITHDRAWN